Follow this preprint
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational study
View ORCID ProfileCarlos K.H. Wong, Ivan C.H. Au, View ORCID ProfileKristy T.K. Lau, Eric H. Y. Lau, View ORCID ProfileBenjamin J. Cowling, View ORCID ProfileGabriel M. Leung
doi: https://doi.org/10.1101/2022.05.26.22275631
Now published in The Lancet doi: 10.1016/S0140-6736(22)01586-0
Carlos K.H. Wong
1Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
2Department of Family Medicine and Primary Care, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
3Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China
PhDIvan C.H. Au
1Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
BScKristy T.K. Lau
1Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
MScEric H. Y. Lau
3Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China
4WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
PhDBenjamin J. Cowling
3Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China
4WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
PhDGabriel M. Leung
3Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China
4WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
M.D
Article usage
Picked up by 12 news outlets
Referenced in 1 policy documents
Tweeted by 396
Posted May 26, 2022.
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational study
Carlos K.H. Wong, Ivan C.H. Au, Kristy T.K. Lau, Eric H. Y. Lau, Benjamin J. Cowling, Gabriel M. Leung
medRxiv 2022.05.26.22275631; doi: https://doi.org/10.1101/2022.05.26.22275631
Now published in The Lancet doi: 10.1016/S0140-6736(22)01586-0
Subject Area
Subject Areas
- Addiction Medicine (409)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3059)
- Dermatology (258)
- Emergency Medicine (458)
- Epidemiology (12991)
- Forensic Medicine (13)
- Gastroenterology (855)
- Genetic and Genomic Medicine (4797)
- Geriatric Medicine (443)
- Health Economics (748)
- Health Informatics (3042)
- Health Policy (1098)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (452)
- Medical Ethics (119)
- Nephrology (495)
- Neurology (4568)
- Nursing (243)
- Nutrition (675)
- Oncology (2370)
- Ophthalmology (671)
- Orthopedics (266)
- Otolaryngology (332)
- Pain Medicine (298)
- Palliative Medicine (86)
- Pathology (514)
- Pediatrics (1234)
- Primary Care Research (516)
- Public and Global Health (7153)
- Radiology and Imaging (1590)
- Respiratory Medicine (941)
- Rheumatology (457)
- Sports Medicine (399)
- Surgery (506)
- Toxicology (64)
- Transplantation (218)
- Urology (188)